Glucocorticoid receptor

Assets acting on this target.

Class
Selective glucocorticoid receptor modulator

The glucocorticoid receptor (GR) is a nuclear hormone receptor that, once bound by cortisol or a synthetic corticosteroid, moves into the cell nucleus and regulates the transcription of many genes. Its natural role is to coordinate the body's response to stress and to restrain inflammation and immune activity. Because of this, GR agonists (corticosteroids) are among the most widely used anti-inflammatory and immunosuppressive medicines, applied topically for skin disease, inhaled for asthma and chronic obstructive pulmonary disease, and given systemically for a broad range of inflammatory and autoimmune conditions. The same receptor, however, also governs glucose metabolism, bone turnover, and fat distribution, so sustained activation can produce metabolic and structural side effects. This has motivated a complementary strategy: selective glucocorticoid receptor modulators and antagonists, which block or fine-tune GR signaling rather than activate it broadly. These agents are relevant in conditions of glucocorticoid excess, such as endogenous cortisol overproduction, or when clinicians wish to counteract corticosteroid-driven metabolic effects while preserving other treatment goals. Together, agonists and modulators illustrate how one receptor can be therapeutically exploited from opposite directions depending on the clinical need.

By indication

Related mechanisms

Glucocorticoid receptor drugs compared

23 drugs, stage by indication
23 drugs acting on Glucocorticoid receptor: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
albuterol / budesonideAirsupraAstraZenecacombination (SABA + ICS)ApprovedApproved in Asthma
Beclomethasone (QVAR)Teva Pharmaceutical Industriessmall molecule (corticosteroid)ApprovedApproved in Asthma
Betamethasone Dipropionate Emollient SpraySernivoEncore Dermatology, Primus Pharmaceuticalssmall moleculeApprovedApproved in Psoriasis
Budesonide (Entocort EC)Entocort ECPadagis, Tillotts Pharma AGsmall moleculeApprovedApproved in Crohn's Disease
budesonide (Ortikos)OrtikosSun Pharmaceutical IndustriesNot recordedApprovedApproved in Crohn's Disease
Budesonide (targeted-release)TARPEYO / NefeconAsahi Kasei Corporation, Calliditas Therapeutics, Everest Medicines (Beijing) Co., Ltd., STADA Arzneimittelsmall moleculeApprovedApproved in IgA Nephropathy
Budesonide (Uceris rectal foam)Uceris rectal foamBausch Healthsmall moleculeApprovedApproved in Ulcerative Colitis
budesonide MMX (Uceris)UcerisBausch Health, Cosmo N.V., Ferring Pharmaceuticalssmall moleculeApprovedApproved in Ulcerative Colitis
ciclesonide (Alvesco)AlvescoAzurity Pharmaceuticalssmall molecule (corticosteroid)ApprovedApproved in Asthma
DexamethasoneNot recordedsmall moleculeApprovedApproved in Crohn's Disease; Approved in Ulcerative Colitis
Dexamethasone (Dextenza)DextenzaAffaMed Therapeutics, OCULAR THERAPEUTIX, INCsmall moleculeApprovedApproved in Allergic Conjunctivitis; Approved in Ocular Inflammation and Pain
Fluticasone FuroateArnuity ElliptaGlaxoSmithKlinesmall molecule (corticosteroid)ApprovedApproved in Asthma
fluticasone furoate/umeclidinium/vilanterolTrelegy ElliptaGlaxoSmithKlinesmall molecule combinationApprovedApproved in Asthma; Approved in Chronic Obstructive Pulmonary Disease
fluticasone furoate/vilanterolBreo ElliptaGlaxoSmithKlinesmall molecule combinationApprovedApproved in Asthma; Approved in Chronic Obstructive Pulmonary Disease
fluticasone propionateGlaxoSmithKlinesmall moleculeApprovedApproved in Asthma
Fluticasone propionate/salmeterol (Advair HFA)Advair HFAGlaxoSmithKlinecombination (ICS + LABA)ApprovedApproved in Asthma
Halobetasol Propionate FoamLexetteMayne Pharmasmall moleculeApprovedApproved in Psoriasis
Halobetasol Propionate LotionBryhaliBausch Healthsmall moleculeApprovedApproved in Psoriasis
hydrocortisone (Cortenema)CortenemaANI Pharmaceuticals, Inc.small moleculeApprovedApproved in Ulcerative Colitis
hydrocortisone acetate (Cortifoam)CortifoamViatrissmall moleculeApprovedApproved in Ulcerative Colitis
Relacorilant (Lifyorli)LifyorliCorcept Therapeuticssmall moleculeApprovedApproved in Ovarian Cancer; Phase 3 in Cushing's Syndrome
DazucorilantCorcept Therapeuticssmall moleculePhase 2Phase 2 in Amyotrophic Lateral Sclerosis
miricorilantCorcept Therapeuticssmall moleculePhase 2Phase 2 in MASH / NASH

← all mechanisms